INDEGENE
Back to Cashflow Statement
|
INDEGENE Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-66 Cr | ₹333 Cr | ₹233 Cr | ₹-132 Cr | ₹136 Cr |
What is the latest Cash Flow from Financing Activities ratio of INDEGENE ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-66 Cr |
Mar2023 | ₹333 Cr |
Mar2022 | ₹233 Cr |
Mar2021 | ₹-132 Cr |
Mar2020 | ₹136 Cr |
How is Cash Flow from Financing Activities of INDEGENE Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-66 Cr | Negative | |
Mar2023 | ₹333 Cr | 42.67 | |
Mar2022 | ₹233 Cr | Positive | |
Mar2021 | ₹-132 Cr | Negative | |
Mar2020 | ₹136 Cr | - |
Compare Cash Flow from Financing Activities of peers of INDEGENE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDEGENE | ₹13,722.0 Cr | 4.7% | 3.4% | NA | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹409,818.0 Cr | -3.3% | 3.4% | 13.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹164,628.0 Cr | 4.1% | 15.2% | 60.2% | Stock Analytics | |
CIPLA | ₹120,775.0 Cr | 0.6% | 5.6% | 11.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,758.0 Cr | 1.9% | 3.7% | 28.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,791.0 Cr | 6.2% | 11.4% | 2.6% | Stock Analytics |
INDEGENE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDEGENE | 4.7% |
3.4% |
|
SENSEX | 0.7% |
9.6% |
10.7% |
You may also like the below Video Courses